Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label single-arm phase II trial of irinotecan plus cisplatin in pediatric high-risk gliomas
2009-010742-59Phase 2Completed
- Sponsor
- Sant Joan de Déu Hospital
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of irinotecan and cisplatin in glioma and brainstem glioma, sponsored by Sant Joan de Déu Hospital. Primary endpoints: Objective response rate and Safety. Started Mar 2009; status: completed.
02
Drugs
irinotecancisplatin
03
Conditions
gliomabrainstem glioma
Beyond the preview
Go deeper on 2009-010742-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010742-59.